A Randomized, Controlled Study of Peginterferon Lambda-1a/Ribavirin ± Daclatasvir for Hepatitis C Virus Genotype 2 or 3
SpringerPlus - Germany
doi 10.1186/s40064-016-2920-z
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 19, 2016
Authors
Publisher
Springer Science and Business Media LLC